Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LACOSAMIDA EUGIA 10 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LACOSAMIDA EUGIA 10 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG

Approved

STANDARD

LACOSAMIDA EUGIA 10 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 28, 2025
Approval ID: 30ad63773c346be6
Company: Eugia Pharma (Malta) Limited
Type: Standard

Approval Details

Approval Id: 30ad63773c346be6
Drug Cima Aemps Name: LACOSAMIDA EUGIA 10 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG
Register Number: 90392
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2025-07-28
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 10 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Eugia Pharma (Malta) Limited

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 28, 2025

Approval ID

30ad63773c346be6

Type

Standard

Back to CIMA-AEMPS Approvals